Pharmaceutical Speakers' Bureaus, Academic Freedom, and the Management of Promotional Speaking at Academic Medical Centers
Journal of Law, Medicine and Ethics 40 (2):311-325 (2012)
AbstractPharmaceutical companies routinely engage physicians, particularly those with prestigious academic credentials, to deliver “educational” talks to groups of physicians in the community to help market the company's brand-name drugs.Although presented as educational, and even though they provide educational content, these events are intended to influence decisions about drug selection in ways that are not based on the suitability and effectiveness of the product, but on the prestige and persuasiveness of the speaker. A number of state legislatures and most academic medical centers have attempted to restrict physician participation in pharmaceutical marketing activities, though most restrictions are not absolute and have proven difficult to enforce. This article reviews the literature on why Speakers' Bureaus have become a lightning rod for academic/industry conflicts of interest and examines the arguments of those who defend physician participation. It considers whether the restrictions on Speakers' Bureaus are consistent with principles of academic freedom and concludes with the legal and institutional efforts to manage industry speaking
Similar books and articles
Academic freedom and academic-industry relationships in biotechnology.Robert Streiffer - 2006 - Kennedy Institute of Ethics Journal 16 (2):129-149.
Ethics, academic freedom and academic tenure.Richard T. De George - 2003 - Journal of Academic Ethics 1 (1):11-25.
Understanding Physician-Pharmaceutical Industry Interactions: A Concise Guide.Shaili Jain - 2007 - Cambridge University Press.
Academic freedom and academic tenure: Can they survive in the market place of ideas? [REVIEW]Chance W. Lewis & BethRené Roepnack - 2007 - Journal of Academic Ethics 5 (2-4):221-232.
In the grip of the python: Conflicts at the university-industry interface.David Healy - 2003 - Science and Engineering Ethics 9 (1):59-71.
Academic Freedom in Europe: Reviewing Unesco's "Recommendation".Terence Karran - 2009 - British Journal of Educational Studies 57 (2):191 - 215.
Pharmaceutical “Gift-Giving,” Medical Education, and Conflict of Interest.Dale Murray & Heather Certain - 2007 - Journal of Philosophical Research 32 (9999):335-343.
Ethical considerations in the use of direct-to-consumer advertising and pharmaceutical promotions: The impact on pharmaceutical sales and physicians. [REVIEW]R. Stephen Parker & Charles E. Pettijohn - 2003 - Journal of Business Ethics 48 (3):279-290.
Added to PP
Historical graph of downloads
Citations of this work
No citations found.
References found in this work
Beyond a pejorative understanding of conflict of interest.Bryn Williams-Jones - 2011 - American Journal of Bioethics 11 (1):1 - 2.
Transparency in Research and its Effect on the Perception of Research Integrity.Marcia M. Boumil & Harris Berman - 2010 - Jona's Healthcare Law, Ethics, and Regulation 12 (3):64-68.
Drug Reps off Campus! Promoting Professional Purity by Suppressing Commercial Speech.Lance K. Stell - 2009 - Journal of Law, Medicine and Ethics 37 (3):431-443.
Drug Reps Off Campus! Promoting Professional Purity by Suppressing Commercial Speech.Lance K. Stell - 2009 - Journal of Law, Medicine and Ethics 37 (3):431-443.
Pharmaceutical Company Gifts: From Voluntary Standards to Legal Demands.Rebecca Dresser - 2006 - Hastings Center Report 36 (3):8-9.